Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial-Reference-Cited by-同舟云学术

Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial

Published:2006-03-28 Issue:7 Volume:94 Page:947-954
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Wilkinson P M, ,Antonopoulos M,Lahousen M,Lind M,Kosmidis P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6603004.pdf

Reference33 articles.

1. Abels RI (1992) Recombinant human erythropoietin in the treatment of the anaemia of cancer. Acta Haematol 87 (Suppl 1): 4–11

2. Barrett-Lee P, Bokemeyer C, Gascón P, Nortier JW, Schneider M, Schrijvers D, Van Belle S, ECAS Advisory Board and Participating Centers (2005) Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey. Oncologist 10: 743–757

3. Barrett-Lee PJ, Bailey NP, O’Brien ME, Wager E (2000) Large-scale U.K. audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 82: 93–97

4. Bohlius J, Langensiepen S, Schwarzer G, Seidenfeld J, Piper M, Bennet C, Engert A (2005) Erythropoietin for patients with malignant disease. The Cochrane Database of Systematic Reviews 2004, Issue 3, Art. No. CD003407.pub2. DOI: 10.1002/14651858.CD003407.pub2

5. Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34: 13–19

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-06-20

2. Recombinant human erythropoietin accelerated the proliferation of non‐small cell lung cancer cell lines and reduced the expression of VEGF, HIF‐1α, and PD‐L1 under a simulated hypoxic environment in vitro;Chronic Diseases and Translational Medicine;2022-03-31

3. Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR Trial;Clinical Breast Cancer;2020-12

4. Pharmacologic Interventions for Fatigue in Cancer and Transplantation: A Meta-Analysis;Current Oncology;2018-04-01

5. Indications for and complications of transfusion and the management of gynecologic malignancies;Gynecologic Oncology;2017-08